Securities Code: 300204 Securities Abbreviation: Shuntai Shen Announcement No.: 2026-035
Shuntai Shen (Beijing) Biopharmaceutical Co., Ltd. Announcement on the Election of Independent Directors and Adjustment of Board Special Committees
The company and all members of the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.
I. Regarding the Election of Independent Directors
Shuntai Shen (Beijing) Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 13th meeting of the Sixth Board of Directors on June 22, 2026, and reviewed and approved the "Proposal on the Election of Independent Directors and Adjustment of Board Special Committees."
After the Nomination Committee's review of the qualification requirements, the Board of Directors nominates Mr. Zhai Yonggong as a candidate for an independent director of the Sixth Board of Directors. His term of office will commence from the date of approval by the Company's First Extraordinary General Meeting of Shareholders in 2026 until the expiration of the term of the Sixth Board of Directors. Mr. Zhai Yonggong's remuneration as an independent director will be in accordance with the Company's remuneration plan for independent directors of the Sixth Board of Directors. This proposal, after being approved by the Board of Directors, needs to be submitted to the General Meeting of Shareholders for deliberation.
The eligibility of the independent director candidate and their independence are subject to the review and approval of the Shenzhen Stock Exchange without objection before the General Meeting of Shareholders can vote. After the supplementary election, the number of directors concurrently serving as senior management personnel and those appointed as employee representatives shall not exceed one-half of the total number of directors of the Company, and the number of independent directors shall not be less than one-third of the total number of directors.